omniture
DAEWOONG PHARMACEUTICAL

Latest News

HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer

SEOUL, South Korea, Feb. 21, 2022 /PRNewswire/ -- HanAll Biopharma (KRX: 009420.KS) announced today...

2022-02-21 22:00 2725

Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Drug Development

* Recorded operating profit KRW 88.9 billion and net profit KRW 31.6 billion in 2021 with the out...

2022-02-21 22:00 2907

Daewoong Pharmaceutical Released Positive Phase 3 Topline Results for New Antidiabetic Drug

SEOUL, South Korea, Jan. 25, 2022 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) has confirmed ...

2022-01-25 22:00 2280

HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update

* 2021 sales of KRW 101.6 billion for a 15% increase from 2020 * 2021 operating profit of KRW 10...

2022-01-20 22:00 3013

Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters

* Advancement of Nabota and prescriptions... KRW 290.6B sales and KRW 22.7B operating income * ...

2021-11-02 21:00 2316

HanAll Biopharma Reports Third Quarter 2021 Results

* Q3'21 sales of KRW 25.5 billion increased 15% from the same period last year * Q3'21 operating ...

2021-10-28 21:00 2730
123